AMP Meets with Senate HELP Committee and Presents a CLIA Modernization Proposal
AMP's Proposal for Modernization of CLIA Regulations for Laboratory Developed Testing Procedures provides assurance of quality, analytical validity, and clinical validity without jeopardizing...
View ArticleThe Journal of Molecular Diagnostics Publishes Article on Next Generation...
Clinical use of next generation sequencing (NGS) was implemented early in cancers and inherited diseases; now, its technology and applications are being applied to infectious diseases.
View ArticleThe Association for Molecular Pathology Announces 2015 Award Recipients
The Association for Molecular Pathology announced today its 2015 award winners for the Award for Excellence in Molecular Diagnostics, the Jeffrey A. Kant Leadership Award, and the AMP Meritorious...
View ArticleCongressman Michael Burgess, MD, Speaks at Session on CLIA Modernization of...
The AMP 2015session, Modernization of CLIA Regulations for Laboratory Developed Testing Procedures, an Update from Washington, featured keynote speaker Congressman Michael Burgess, MD (R-TX), a member...
View ArticleAMP Symposium on Coding, Coverage, and Reimbursement of Molecular Diagnostic...
The session included presentations from various leaders in the field, all of whom are very knowledgeable regarding reimbursement for molecular diagnostic tests. Rina Wolf, MHA, XIFIN, Inc., gave a...
View ArticleAMP Submits Written Testimony for Hearing on "Examining the Regulation of...
AMP submitted written testimony to the House Energy and Commerce Subcommittee on Health for their hearing on "Examining the Regulation of Diagnostic Tests and Laboratory Operations." AMP urged the...
View ArticleAMP Responds to FDA Report on Oversight of Laboratory Developed Testing...
AMP has responded to FDA's recently released report titled "The Public Health Evidence for FDA Oversight of Laboratory Developed Tests: 20 Case Studies" with a detailed analysis of the laboratory...
View ArticleAMP Updates Pathology Residency Curriculum Recommendations
The paper provides residency programs with specific recommendations from subject matter experts on 10 major molecular pathology topics: basic molecular pathology goals and laboratory management; basic...
View ArticleAMP Issues Statement Regarding FDA Letter to Texas Children's Hospital and...
The Association for Molecular Pathology (AMP), the premier global, professional society serving molecular diagnostics professionals, is very concerned and disappointed to see the FDA taking enforcement...
View ArticleAMP Releases Results from 2015 Genomic Sequencing Procedure Microcosting and...
In 2014, AMP, with the help of Boston Healthcare Associates, gathered more than a dozen protocols to analyze cost information about laboratory validation, pre-analytics, sequencing, bioinformatics, and...
View ArticleInternational Lung Cancer Experts Seek Public Comments on Revised Molecular...
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced today the open comment period...
View ArticleAMP Looks Forward to Working with FDA on Guidance for Next-Generation...
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today announced that it looks forward to working with the U.S....
View ArticleThe Association for Molecular Pathology Establishes New Standard for Clinical...
AMP has established new standards for defining and assessing the clinical utility of molecular diagnostic testing procedures for inherited diseases and cancer. In a new report published in The Journal...
View ArticleAMP to Recognize Eric Lander with 2016 Award for Excellence in Molecular...
Eric Lander, PhD, President and Founding Director of the Broad Institute of MIT and Harvard, and Professor of Biology at MIT and Professor of Systems Biology at Harvard Medical School, has earned this...
View ArticleMedia Alert: Complimentary Media Registrations for Upcoming Association for...
Complimentary media registration packages are available for AMP's upcoming 2016 Annual Meeting in Charlotte, North Carolina.
View ArticleMedia Alert: Association for Molecular Pathology to Participate in Senate...
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today announced two upcoming events designed to help engage key...
View ArticleAssociation for Molecular Pathology Appreciates Opportunity to Discuss with...
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostics professionals, recently participated in two events designed to help educate...
View ArticleAssociation for Molecular Pathology Announces 2016 Award Recipients
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostics professionals, today announced the recipients of the Jeffrey A. Kant Leadership...
View ArticleThe Association for Molecular Pathology Explores New Technological...
AMP has announced a new report that examines how sophisticated technology advancements are being implemented to improve diagnosis and optimize treatment selection for multiple invasive, opportunistic...
View ArticleAMP Applauds FDA's Decision to Delay Final Regulatory Guidance for Laboratory...
AMP Applauds FDA's Decision to Delay Final Regulatory Guidance for Laboratory Developed Procedures
View Article